Cingulate (CINGW) Tax Rate (2022 - 2026)
Cingulate's (CINGW) quarterly Tax Rate came in at 21.0% in Q2 2026, up 4.0% on a YoY basis from 20.19% in Q2 2025, and little changed quarter-over-quarter from 21.02% in Q4 2025.
Analysis
Cingulate (CINGW) Tax Rate (2022 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Tax Rate for 5 consecutive years, with 21.0% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate rose 4.0% year-over-year to 21.0%; the trailing twelve-month figure through Jun 2026 stood at 21.0% (up 1.0% YoY), and the FY2025 full-year result was 21.0%, changed 0.0% from the prior year.
- Tax Rate was little changed at 21.0% in Q2 2026 per CINGW's latest filing, from 21.02% in the prior quarter.
- Across five years, Tax Rate topped out at 22.12% in Q2 2024 and bottomed at 19.79% in Q1 2024.
- Historically, Tax Rate has averaged 20.99% across 5 years, with a median of 21.0% in 2023.
- The sharpest annual moves came in 2024 and 2025: Tax Rate sank 121 bps in 2024, then surged 121 bps in 2025.
- Over 5 years, Tax Rate stood at 21.24% in 2022, then decreased by 2 bps to 20.92% in 2023, then climbed by 0 bps to 21.0% in 2024, then increased by 0 bps to 21.02% in 2025, then declined by 0 bps to 21.0% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 21.0%, 21.02%, and 21.0% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.70 Bn | 623.94 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 441.16 Bn | 434.59 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 364.92 Bn | 357.78 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 266.48 Bn | 258.79 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 52.53 Bn | 45.15 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 44.20 Bn | 44.20 Bn | - | - |
| 8 | Incyte | 25.27 Bn | 20.74 Bn | 1.57 Bn | 22.08% |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | 10.65% |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 21.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.00% |
| Dec 31, 2025 | 21.02% |
| Sep 30, 2025 | 21.00% |
| Jun 30, 2025 | 20.96% |
| Mar 31, 2025 | 21.00% |
| Dec 31, 2024 | 21.00% |
| Sep 30, 2024 | 21.00% |
| Jun 30, 2024 | 22.12% |
| Mar 31, 2024 | 19.79% |
| Dec 31, 2023 | 20.92% |
| Sep 30, 2023 | 21.00% |
| Jun 30, 2023 | 21.00% |
| Mar 31, 2023 | 21.00% |
| Dec 31, 2022 | 21.24% |
| Sep 30, 2022 | 21.00% |
| Jun 30, 2022 | 21.00% |
| Mar 31, 2022 | 20.78% |